MedTrace Logo

Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg

NCT01684137 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-09-12

No results posted yet for this study

Summary

Reduction of the total IgE antibody, improved vital capacity and lung volume measured by spirometry.

Improving quality of life observed in the visual analogue scale (VAS).

Conditions

  • Children

Interventions

DIETARY_SUPPLEMENT

Joalis Bambi Analerg

DIETARY_SUPPLEMENT

Joalis Bambi Bronchi

DIETARY_SUPPLEMENT

Placebo

Sugar pill manufactured to mimic Joalis Bambi Analerg

DIETARY_SUPPLEMENT

Placebo

Sugar pill manufactured to mimic Joalis Bambi Bronchi

Sponsors & Collaborators

  • DSC Services, s.r.o.

    lead INDUSTRY

Principal Investigators

  • Karel Chroust, RNDr., Ing., PhD. · DSC Services, s.r.o.

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684137 on ClinicalTrials.gov